Breaking News Instant updates and real-time market news.

APY

Apergy

$0.00

(0.00%)

, DDD

3D Systems

$10.21

-0.19 (-1.83%)

18:22
05/02/18
05/02
18:22
05/02/18
18:22

S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices

Apergy (APY) will replace 3D Systems (DDD) in the S&P MidCap 400, and 3D Systems will replace Impax Laboratories (IPXL) in the S&P SmallCap 600 effective prior to the open of trading on Thursday, May 10, 2018. S&P 500 constituent Dover (DOV) is spinning off Apergy in a transaction expected to be completed prior to the open on Wednesday, May 9, pending final conditions. Dover will remain in the S&P 500 following the spin-off transaction. 3D Systems has a market capitalization that is more representative of the small-cap market space. Impax Laboratories, which is combining with privately held Amneal Pharmaceuticals, is changing its name to Amneal Pharmaceuticals and its ticker symbol (AMRX) effective on or about May 4. The newly combined company will no longer be eligible for inclusion in the S&P SmallCap 600 as its Investable Weight Factor, which measures the percentage of free float available to the public, is expected to fall well below the 50% eligibility threshold needed for continued inclusion in the index.

APY

Apergy

$0.00

(0.00%)

DDD

3D Systems

$10.21

-0.19 (-1.83%)

IPXL

Merged into AMRX

$20.20

0.35 (1.76%)

DOV

Dover

$89.80

-2.04 (-2.22%)

  • 02

    May

  • 21

    May

APY Apergy
$0.00

(0.00%)

DDD 3D Systems
$10.21

-0.19 (-1.83%)

11/20/17
11/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jennifer Fritzsche saying after dropping 16% since mid-January, "much of the bad news is behind the stock" in terms of wireless service revenue declines. 2. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying he sees limited downside from current share levels. 3. Viacom (VIAB, VIA) upgraded to Hold from Sell at Deutsche Bank with analyst Bryan Kraft saying he sees limited room for further multiple compression. 4. Maxwell (MXWL) upgraded to Buy from Neutral at Roth Capital with analyst Craig Irwin saying he sees consensus estimates as achievable for 2018, and merger synergies with NessCap should start making a more material contribution over the next few quarters. 5. National Beverage (FIZZ) upgraded to Positive from Neutral at Susquehanna with analyst Pablo Zuanic citing his increased conviction on the sales and bottom-line upside of the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/18
JPMS
02/09/18
DOWNGRADE
Target $11
JPMS
Underweight
3D Systems downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Paul Coster downgraded 3D Systems to Underweight with an $11 price target.
02/09/18
JPMS
02/09/18
DOWNGRADE
Target $11
JPMS
Underweight
JPMorgan downgrades 3D Systems to Underweight after 14% year-to-date rally
JPMorgan analyst Paul Coster downgraded 3D Systems to Underweight from Neutral with the shares up 14% year-to-date. The current multiple prices in a return to growth that will prove premature, Coster tells investors in a research note. He expects 3D Systems will underperform the mean of his coverage over the next 6-12 months, but does not view the stock as a good short. The analyst keeps an $11 price target on the shares. 3D Systems closed yesterday down 50c to $9.82.
03/15/18
NEED
03/15/18
NO CHANGE
NEED
Hold
3D Systems Q4 earnings driven by Services, says Needham
Needham analyst James Ricchiuti writes that the Q4 earnings beat for 3D systems was driven by Services, particularly Healthcare, while Printer unit revenues continued to lag. Ricchiuti adds that the company has "several new products" launching this year, but a boost to its hardware system may still be several quarters away. The analyst keeps his Hold rating on 3D Systems.
IPXL Merged into AMRX
$20.20

0.35 (1.76%)

03/07/18
RHCO
03/07/18
INITIATION
Target $24
RHCO
Buy
Impax initiated with a Buy at SunTrust
SunTrust analyst John Boris initiated Impax with a Buy rating and a price target of $24. Boris says the NewCo of Impax and Amneal combines to form the 5th largest global generics company poised for long term expansion, with estimated sales and EBITDA annualized growth of over 49% and 95% respectively. The analyst also points to company's "robust" free cash flow generation while it pays down its debt.
05/01/18
LEHM
05/01/18
INITIATION
Target $27
LEHM
Overweight
Impax initiated with an Overweight at Barclays
Barclays analyst Douglas Tsao started Impax Laboratories with an Overweight rating and $27 price target. The analyst believes the pending merger with Amneal will generate a generics market leader with attractive growth.
03/07/18
03/07/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Marvell (MRVL) initiated with a Buy at Argus. 2. Barrett Business (BBSI) resumed with a Buy at Roth Capital. 3. Impax (IPXL) initiated with a Buy at SunTrust. 4. CTI BioPharma (CTIC) initiated with an Outperform at JMP Securities. 5. Mindbody (MB) initiated with a Buy at Summit Insights. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
LEER
01/18/18
NO CHANGE
LEER
Hospitals' entrant could add to generic industry headwinds, says Leerink
After the New York Times reported that a number of the U.S.'s largest hospital systems plan to create a non-profit generic drug company to fight high prices and drug shortages, Leerink analyst Ami Fadia said she doesn't expect this to have an immediate significant impact on pricing, but does view the news as a continuation of the pricing headwinds seen over the past few years. While unclear what development stage the new generics company is at, the formation of such a company would add one more occupant in an already crowded space, added Fadia. Companies in the generic drug space include Teva (TEVA), Mylan (MYL), Novartis (NVS), Endo (ENDP) and Impax (IPXL).
DOV Dover
$89.80

-2.04 (-2.22%)

03/26/18
JPMS
03/26/18
DOWNGRADE
JPMS
Neutral
Dover downgraded to Neutral from Overweight at JPMorgan
JP Morgan analyst Steve Tusa downgraded Dover to Neutral saying a lack of near-term catalysts makes the risk/reward profile no longer attractive. The analyst has a $112 price target for the shares.
03/26/18
03/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Adobe (ADBE) downgraded to Market Perform from Outperform at JMP Securities with analyst Patrick Walravens saying he believes the shares are fairly valued after having risen 69% in 2017 and a further 21% year-to-date. 2. Dover (DOV) downgraded to Neutral from Overweight at JPMorgan with analyst Steve Tusa saying a lack of near-term catalysts makes the risk/reward profile no longer attractive. 3. AMD (AMD) downgraded to Negative from Neutral at Susquehanna with analyst Christopher Rolland saying he confirmed Bitmain has developed an ASIC for Ethereum mining, which he believes accounted for roughly 20% of AMD's sales. 4. Jack in the Box (JACK) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst John Glass saying he sees limited upside and ongoing top-line risk. 5. Willis Towers Watson (WLTW) downgraded to Underperform from Neutral at BofA/Merrill with analyst Jay Cohen saying while Willis' organic growth rebounded in 2017, its inconsistent margin performance detracts a bit from his confidence in the company's near-term earnings power. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/18
BOFA
04/03/18
NO CHANGE
BOFA
BofA/Merrill's Top 10 US Ideas for Q2 2018
BofA/Merrill introduced its Top 10 Ideas for Q2 2018. They are Buy rated Abbott (ABT), ADP (ADP),Coca-Cola European Partners (CCE), Discovery (DISCA), Dover (DOV), Lowe's (LOW), MGM Resorts (MGM), and Qualcomm (QCOM), and Underperform rated Ralph Lauren (RL) and BlackBerry (BB).
02/15/18
LEHM
02/15/18
INITIATION
Target $120
LEHM
Overweight
Dover initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started Dover with an Overweight rating and $120 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.

TODAY'S FREE FLY STORIES

TSCO

Tractor Supply

$97.56

0.53 (0.55%)

14:42
02/20/19
02/20
14:42
02/20/19
14:42
Conference/Events
Tractor Supply management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 06

    Mar

PWR

Quanta Services

$36.49

0.815 (2.28%)

14:40
02/20/19
02/20
14:40
02/20/19
14:40
Options
Repeat put buyers in Quanta Services ahead of earnings »

Repeat put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EADSY

Airbus

$0.00

(0.00%)

14:38
02/20/19
02/20
14:38
02/20/19
14:38
Conference/Events
Airbus management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NTR

Nutrien

$54.57

1.22 (2.29%)

14:35
02/20/19
02/20
14:35
02/20/19
14:35
Options
Nutrien put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

14:35
02/20/19
02/20
14:35
02/20/19
14:35
General news
On the balance sheet: »

On the balance sheet: the…

SSNLF

Samsung

$0.00

(0.00%)

, VZ

Verizon

$55.67

0.24 (0.43%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Periodicals
Samsung unveils Galaxy S10 5G, Verge reports »

Samsung (SSNLF) intends…

SSNLF

Samsung

$0.00

(0.00%)

VZ

Verizon

$55.67

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

  • 11

    Mar

FDP

Fresh Del Monte

$29.80

0.53 (1.81%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Hot Stocks
Breaking Hot Stocks news story on Fresh Del Monte »

Fresh Del Monte trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$7.52

-0.17 (-2.21%)

, AMGN

Amgen

$187.14

0.17 (0.09%)

14:27
02/20/19
02/20
14:27
02/20/19
14:27
Recommendations
Cytokinetics, Amgen analyst commentary  »

Piper reiterates…

CYTK

Cytokinetics

$7.52

-0.17 (-2.21%)

AMGN

Amgen

$187.14

0.17 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 28

    Feb

  • 01

    Mar

GG

Goldcorp

$11.52

0.25 (2.22%)

14:25
02/20/19
02/20
14:25
02/20/19
14:25
Options
Goldcorp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
02/20/19
02/20
14:25
02/20/19
14:25
General news
FX Action: The Dollar »

FX Action: The Dollar…

SSNLF

Samsung

$0.00

(0.00%)

, AAPL

Apple

$172.67

1.72 (1.01%)

14:23
02/20/19
02/20
14:23
02/20/19
14:23
Periodicals
Samsung unveils new foldable phone called Galaxy Fold, Verge reports »

At Samsung's Galaxy…

SSNLF

Samsung

$0.00

(0.00%)

AAPL

Apple

$172.67

1.72 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

FDP

Fresh Del Monte

$29.80

0.53 (1.81%)

14:20
02/20/19
02/20
14:20
02/20/19
14:20
Hot Stocks
Fresh Del Monte board suspends quarterly cash dividend »

Fresh Del Monte Produce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
02/20/19
02/20
14:20
02/20/19
14:20
General news
FOMC minutes to Januayr 29, 30 meeting: »

FOMC minutes to Januayr…

NXTM

NxStage Medical

$29.99

0.35 (1.18%)

, FMS

Fresenius Medical

$40.17

1.79 (4.66%)

14:18
02/20/19
02/20
14:18
02/20/19
14:18
Hot Stocks
FTC requires NxStage, Fresenius Medical to divest bloodline tubing assets »

The Federal Trade…

NXTM

NxStage Medical

$29.99

0.35 (1.18%)

FMS

Fresenius Medical

$40.17

1.79 (4.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 05

    Mar

  • 12

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
02/20/19
02/20
14:17
02/20/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
02/20/19
02/20
14:16
02/20/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$54.65

-0.65 (-1.18%)

14:15
02/20/19
02/20
14:15
02/20/19
14:15
Options
Etsy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.60

0.71 (0.26%)

14:09
02/20/19
02/20
14:09
02/20/19
14:09
General news
'Almost all' Fed members wanted to announce plan to stop reducing assets »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.60

0.71 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.27

0.38 (0.14%)

14:06
02/20/19
02/20
14:06
02/20/19
14:06
General news
Fed saw 'variety of considerations' for 'patient approach to monetary policy' »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.27

0.38 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.32

0.43 (0.15%)

14:05
02/20/19
02/20
14:05
02/20/19
14:05
General news
Fed to continue monitoring economic developments for outlook implications »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.32

0.43 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.34

0.45 (0.16%)

14:02
02/20/19
02/20
14:02
02/20/19
14:02
General news
Fed sees 'sustained expansion of economic activity' as most likely outcome »

Minutes from the last…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.34

0.45 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDP

Fresh Del Monte

$29.97

0.7 (2.39%)

14:00
02/20/19
02/20
14:00
02/20/19
14:00
Hot Stocks
Breaking Hot Stocks news story on Fresh Del Monte »

Fresh Del Monte trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$23.13

-2.04 (-8.10%)

14:00
02/20/19
02/20
14:00
02/20/19
14:00
Options
Dip buyer in Bausch Health Companies »

Dip buyer in Bausch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 12

    Mar

VLKAY

Volkswagen

$0.00

(0.00%)

, AUDVF

Audi AG

$0.00

(0.00%)

13:59
02/20/19
02/20
13:59
02/20/19
13:59
Periodicals
Audi plans to cut 10% of management positions, Reuters reports »

Audi (AUDVF),…

VLKAY

Volkswagen

$0.00

(0.00%)

AUDVF

Audi AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$146.31

-15.45 (-9.55%)

13:58
02/20/19
02/20
13:58
02/20/19
13:58
On The Fly
Trade Desk slides after analyst cuts rating ahead of quarterly results »

Shares of Trade Desk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 06

    Mar

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.